Functionally Cloned pdrM from Streptococcus pneumoniae Encodes a Na+ Coupled Multidrug Efflux Pump

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Hashimoto, Kohei ^a   Ogawa, Wakano ^a   Nishioka, Toshihiro ^a   Tsuchiya, Tomofusa ^a,b   Kuroda, Teruo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ACRIFLAVINE; BENZALKONIUM CHLORIDE; CHLORAMPHENICOL; CIPROFLOXACIN; ENOXACIN; ERYTHROMYCIN; ETHIDIUM BROMIDE; LITHIUM ION; MESSENGER RNA; NORFLOXACIN; OFLOXACIN; RHODAMINE; SODIUM ION; TETRAPHENYLPHOSPHONIUM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL GROWTH; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; GENE; GENE EXPRESSION; GENE FUNCTION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; NORM GENE; NUCLEOTIDE SEQUENCE; PDRM GENE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SODIUM TRANSPORT; SPR1756 GENE; SPR1877 GENE; STREPTOCOCCUS PNEUMONIAE; VIBRIO PARAHAEMOLYTICUS; YDHE GENE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CLONING, MOLECULAR; GENES, MDR; MICROBIAL SENSITIVITY TESTS; PLASMIDS; SEQUENCE ANALYSIS; SODIUM; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; STREPTOCOCCUS PNEUMONIAE; VIBRIO PARAHAEMOLYTICUS;

EID: 84875475864     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059525     Document Type: Article

References (70)

1. Diaz A, Barria P, Niederman M, Restrepo MI, Dreyse J, et al. (2007) Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens. Chest 131: 779-787.
2. Vainio A, Lyytikainen O, Sihvonen R, Kaijalainen T, Teirila L, et al. (2009) An outbreak of pneumonia associated with S. pneumoniae at a military training facility in Finland in 2006. APMIS 117: 488-491.
3. Lagos R, Munoz A, San Martin O, Maldonado A, Hormazabal JC, et al. (2008) Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994-2007. J Infect Dis 198: 1809-1817.
4. Sousa D, Justo I, Dominguez A, Manzur A, Izquierdo C, et al. (2012) Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome. Clin Microbiol Infect 10 (1111/j.1469-0691.2012.03765) ():: x.
5. Gentile A, Bardach A, Ciapponi A, Garcia-Marti S, Aruj P, et al. (2012) Epidemiology of community-acquired pneumonia in children of Latin America and the Caribbean: a systematic review and meta-analysis. Int J Infect Dis 16: e5-15.
6. Bamba M, Jozaki K, Sugaya N, Tamai S, Ishihara J, et al. (2006) Prospective surveillance for atypical pathogens in children with community-acquired pneumonia in Japan. J Infect Chemother 12: 36-41.
7. Tajima T, Nakayama E, Kondo Y, Hirai F, Ito H, et al. (2006) Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children. J Infect Chemother 12: 372-379.
8. Yanagihara K, Izumikawa K, Higa F, Tateyama M, Tokimatsu I, et al. (2009) Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection. Intern Med 48: 527-535.
9. Umeki K, Tokimatsu I, Yasuda C, Iwata A, Yoshioka D, et al. (2011) Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia. Respirology 16: 856-861.
10. Mitchell AM, Mitchell TJ, (2010) Streptococcus pneumoniae: virulence factors and variation. Clin Microbiol Infect 16: 411-418.
11. Jenkins SG, Farrell DJ, (2009) Increase in pneumococcus macrolide resistance, United States. Emerg Infect Dis 15: 1260-1264.
12. Rantala M, Huikko S, Huovinen P, Jalava J, (2005) Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002. Antimicrob Agents Chemother 49: 4180-4184.
13. Mera RM, Miller LA, Daniels JJ, Weil JG, White AR, (2005) Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project. Diagn Microbiol Infect Dis 51: 195-200.
14. Song JH, Jung SI, Ko KS, Kim NY, Son JS, et al. (2004) High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 48: 2101-2107.
15. Imai S, Ito Y, Ishida T, Hirai T, Ito I, et al. (2009) High prevalence of multidrug-resistant Pneumococcal molecular epidemiology network clones among Streptococcus pneumoniae isolates from adult patients with community-acquired pneumonia in Japan. Clin Microbiol Infect 15: 1039-1045.
16. Ishida T, Maniwa K, Kagioka H, Hirabayashi M, Onaru K, et al. (2008) Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan. Respirology 13: 240-246.
17. Hotomi M, Billal DS, Kamide Y, Kanesada K, Uno Y, et al. (2008) Serotype distribution and penicillin resistance of Streptococcus pneumoniae isolates from middle ear fluids of pediatric patients with acute otitis media in Japan. J Clin Microbiol 46: 3808-3810.
18. Maekawa M, Fukuda Y, Sugiura Y, Kamiyama T, Futakuchi N, et al. (2003) [Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae]. Jpn J Antibiot 56: 27-35.
19. Piddock LJ, White DG, Gensberg K, Pumbwe L, Griggs DJ, (2000) Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 44: 3118-3121.
20. Sulavik MC, Houseweart C, Cramer C, Jiwani N, Murgolo N, et al. (2001) Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother 45: 1126-1136.
21. Hsieh PC, Siegel SA, Rogers B, Davis D, Lewis K, (1998) Bacteria lacking a multidrug pump: a sensitive tool for drug discovery. Proc Natl Acad Sci U S A 95: 6602-6606.
22. Morita Y, Komori Y, Mima T, Kuroda T, Mizushima T, et al. (2001) Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump. FEMS Microbiol Lett 202: 139-143.
23. Gill MJ, Brenwald NP, Wise R, (1999) Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 43: 187-189.
24. Tait-Kamradt A, Clancy J, Cronan M, Dib-Hajj F, Wondrack L, et al. (1997) mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother 41: 2251-2255.
25. Marrer E, Schad K, Satoh AT, Page MG, Johnson MM, et al. (2006) Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae. Antimicrob Agents Chemother 50: 685-693.
26. Saier MH Jr, Paulsen IT, (2001) Phylogeny of multidrug transporters. Semin Cell Dev Biol 12: 205-213.
27. Boncoeur E, Durmort C, Bernay B, Ebel C, Di Guilmi AM, et al. (2012) PatA and PatB form a functional heterodimeric ABC multidrug efflux transporter responsible for the resistance of Streptococcus pneumoniae to fluoroquinolones. Biochemistry 51: 7755-7765.
28. Kuroda T, Tsuchiya T, (2009) Multidrug efflux transporters in the MATE family. Biochim Biophys Acta 1794: 763-768.
29. He X, Szewczyk P, Karyakin A, Evin M, Hong WX,et al. Structure of a cation-bound multidrug and toxic compound extrusion transporter. Nature 467: 991-994.
30. Morita Y, Kataoka A, Shiota S, Mizushima T, Tsuchiya T, (2000) NorM of Vibrio parahaemolyticus is an Na(+)-driven multidrug efflux pump. J Bacteriol 182: 6694-6697.
31. Huda MN, Morita Y, Kuroda T, Mizushima T, Tsuchiya T, (2001) Na+-driven multidrug efflux pump VcmA from Vibrio cholerae non-O1, a non-halophilic bacterium. FEMS Microbiol Lett 203: 235-239.
32. Chen J, Morita Y, Huda MN, Kuroda T, Mizushima T, et al. (2002) VmrA, a member of a novel class of Na(+)-coupled multidrug efflux pumps from Vibrio parahaemolyticus. J Bacteriol 184: 572-576.
33. Huda MN, Chen J, Morita Y, Kuroda T, Mizushima T, et al. (2003) Gene cloning and characterization of VcrM, a Na+-coupled multidrug efflux pump, from Vibrio cholerae non-O1. Microbiol Immunol 47: 419-427.
34. Xu XJ, Su XZ, Morita Y, Kuroda T, Mizushima T, et al. (2003) Molecular cloning and characterization of the HmrM multidrug efflux pump from Haemophilus influenzae Rd. Microbiol Immunol 47: 937-943.
35. Long F, Rouquette-Loughlin C, Shafer WM, Yu EW, (2008) Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli. Antimicrob Agents Chemother 52: 3052-3060.
36. Berns KI, Thomas CA Jr, (1965) Isolation of High Molecular Weight DNA from Hemophilus Influenzae. J Mol Biol 11: 476-490.
37. Tanaka S, Lerner SA, Lin EC, (1967) Replacement of a phosphoenolpyruvate-dependent phosphotransferase by a nicotinamide adenine dinucleotide-linked dehydrogenase for the utilization of mannitol. J Bacteriol 93: 642-648.
38. Lee EW, Chen J, Huda MN, Kuroda T, Mizushima T, et al. (2003) Functional cloning and expression of emeA, and characterization of EmeA, a multidrug efflux pump from Enterococcus faecalis. Biol Pharm Bull 26: 266-270.
39. Lopilato J, Tsuchiya T, Wilson TH, (1978) Role of Na+ and Li+ in thiomethylgalactoside transport by the melibiose transport system of Escherichia coli. J Bacteriol 134: 147-156.
40. Tsuchiya T, Wilson TH, (1978) Cation-sugar cotransport in the melibiose transport system of Escherichia coli. Membr Biochem 2: 63-79.
41. Tsuchiya T, Raven J, Wilson TH, (1977) Co-transport of Na+ and methul-beta-D-thiogalactopyranoside mediated by the melibiose transport system of Escherichia coli. Biochem Biophys Res Commun 76: 26-31.
42. Spizizen J, (1958) Transformation of biochemically deficient strains of Bacillus subtilis by deoxyribonucleate. Proc Natl Acad Sci U S A 44: 1072-1078.
43. Ochi K, Kim JY, Tanaka Y, Wang G, Masuda K, et al. (2009) Inactivation of KsgA, a 16 S rRNA methyltransferase, causes vigorous emergence of mutants with high-level kasugamycin resistance. Antimicrob Agents Chemother 53: 193-201.
44. Hoskins J, Alborn WE Jr, Arnold J, Blaszczak LC, Burgett S, et al. (2001) Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol 183: 5709-5717.
45. Turnbough CL Jr, Switzer RL, (2008) Regulation of pyrimidine biosynthetic gene expression in bacteria: repression without repressors. Microbiol Mol Biol Rev 72: 266-300.
46. Huang M, Oppermann-Sanio FB, Steinbuchel A, (1999) Biochemical and molecular characterization of the Bacillus subtilis acetoin catabolic pathway. J Bacteriol 181: 3837-3841.
47. Omote H, Hiasa M, Matsumoto T, Otsuka M, Moriyama Y, (2006) The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations. Trends Pharmacol Sci 27: 587-593.
48. Neyfakh AA, (1992) The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrob Agents Chemother 36: 484-485.
49. Masaoka Y, Ueno Y, Morita Y, Kuroda T, Mizushima T, et al. (2000) A two-component multidrug efflux pump, EbrAB, in Bacillus subtilis. J Bacteriol 182: 2307-2310.
50. Ahmed M, Lyass L, Markham PN, Taylor SS, Vazquez-Laslop N, et al. (1995) Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulated. J Bacteriol 177: 3904-3910.
51. Steinfels E, Orelle C, Fantino JR, Dalmas O, Rigaud JL, et al. (2004) Characterization of YvcC (BmrA), a multidrug ABC transporter constitutively expressed in Bacillus subtilis. Biochemistry 43: 7491-7502.
52. Tsuge K, Ohata Y, Shoda M, (2001) Gene yerP, involved in surfactin self-resistance in Bacillus subtilis. Antimicrob Agents Chemother 45: 3566-3573.
53. Ohki R, Murata M, (1997) bmr3, a third multidrug transporter gene of Bacillus subtilis. J Bacteriol 179: 1423-1427.
54. Kuroda T, Shimamoto T, Inaba K, Tsuda M, Tsuchiya T, (1994) Properties and sequence of the NhaA Na+/H+ antiporter of Vibrio parahaemolyticus. J Biochem 116: 1030-1038.
55. Mortier-Barriere I, de Saizieu A, Claverys JP, Martin B, (1998) Competence-specific induction of recA is required for full recombination proficiency during transformation in Streptococcus pneumoniae. Mol Microbiol 27: 159-170.
56. Tocci N, Iannelli F, Bidossi A, Ciusa ML, Decorosi F, et al. (2013) Functional Analysis of Pneumococcal Drug Efflux Pumps Associates the MATE DinF Transporter with Quinolone Susceptibility. Antimicrob Agents Chemother 57: 248-253.
57. Brown MH, Paulsen IT, Skurray RA, (1999) The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol Microbiol 31: 394-395.
58. McAleese F, Petersen P, Ruzin A, Dunman PM, Murphy E, et al. (2005) A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob Agents Chemother 49: 1865-1871.
59. Brown DG, Swanson JK, Allen C, (2007) Two host-induced Ralstonia solanacearum genes, acrA and dinF, encode multidrug efflux pumps and contribute to bacterial wilt virulence. Appl Environ Microbiol 73: 2777-2786.
60. Munoz-Elias EJ, Marcano J, Camilli A, (2008) Isolation of Streptococcus pneumoniae biofilm mutants and their characterization during nasopharyngeal colonization. Infect Immun 76: 5049-5061.
61. Su XZ, Chen J, Mizushima T, Kuroda T, Tsuchiya T, (2005) AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob Agents Chemother 49: 4362-4364.
62. Murata T, Kawano M, Igarashi K, Yamato I, Kakinuma Y, (2001) Catalytic properties of Na(+)-translocating V-ATPase in Enterococcus hirae. Biochim Biophys Acta 1505: 75-81.
63. Kakinuma Y, (1987) Sodium/proton antiporter in Streptococcus faecalis. J Bacteriol 169: 3886-3890.
64. Russell JB, Strobel HJ, Driessen AJ, Konings WN, (1988) Sodium-dependent transport of neutral amino acids by whole cells and membrane vesicles of Streptococcus bovis, a ruminal bacterium. J Bacteriol 170: 3531-3536.
65. Utsugi J, Inaba K, Kuroda T, Tsuda M, Tsuchiya T, (1998) Cloning and sequencing of a novel Na+/H+ antiporter gene from Pseudomonas aeruginosa. Biochim Biophys Acta 1398: 330-334.
66. Pinner E, Padan E, Schuldiner S, (1992) Cloning, sequencing, and expression of the nhaB gene, encoding a Na+/H+ antiporter in Escherichia coli. J Biol Chem 267: 11064-11068.
67. Hiramatsu T, Kodama K, Kuroda T, Mizushima T, Tsuchiya T, (1998) A putative multisubunit Na+/H+ antiporter from Staphylococcus aureus. J Bacteriol 180: 6642-6648.
68. Collins JF, Honda T, Knobel S, Bulus NM, Conary J, et al. (1993) Molecular cloning, sequencing, tissue distribution, and functional expression of a Na+/H+ exchanger (NHE-2). Proc Natl Acad Sci U S A 90: 3938-3942.
69. Ogawa W, Kim YM, Mizushima T, Tsuchiya T, (1998) Cloning and expression of the gene for the Na+-coupled serine transporter from Escherichia coli and characteristics of the transporter. J Bacteriol 180: 6749-6752.
70. MacLeod PR, MacLeod RA, (1992) Identification and sequence of a Na(+)-linked gene from the marine bacterium Alteromonas haloplanktis which functionally complements the dagA gene of Escherichia coli. Mol Microbiol 6: 2673-2681.